Namzaric® for Irradiated Primary Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled 24-Week Clinical Trial
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Allergan, Inc.
Start Date
July 19, 2021
End Date
December 15, 2023
Administered By
Duke Cancer Institute
Awarded By
Allergan, Inc.
Start Date
July 19, 2021
End Date
December 15, 2023